Fig. 2From: Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in USSurvival curves used in the long-term extrapolation model. BSC best supportive care, OS overall survival, VFS ventilation-free survival.*Survival in “not sitting” health state in treatment arm is the same as survival on permanent ventilationBack to article page